Pharmacovigilance, signal detection and signal intelligence overview

Fusion 2011 - 14th International Conference on Information Fusion

Volumn , Issue , 2011, Pages

  Shibata, Atsuko ^a   Hauben, Manfred ^b  

^a AMGEN INC   (United States)

^b PFIZER INC   (United States)

Author keywords

Drug safety; Pharmacovigilance; Safety surveillance; Signal detection; Signal intelligence

Indexed keywords

ADVERSE EVENTS; CROSS-FUNCTIONAL; DETECTION FRAMEWORK; DRUG SAFETY; EMERGING TRENDS; MARGINAL DISTRIBUTION; PHARMACOVIGILANCE; SAFETY MONITORING; SIGNAL INTELLIGENCE; STATISTICAL DATAS;

DRUG PRODUCTS; INFORMATION FUSION; STATISTICAL METHODS;

SIGNAL DETECTION;

EID: 80052531313     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (4)

1. World Health Organization. The importance of pharmacovigilance - safety monitoring of medicinal products. World Health Organization, Geneva, 2002.
2. Hauben M and Aronson JK, Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Safety, 2009, 32(2):99-110.
3. CIOMS Working Group VIII. Practical aspects of signal detection in pharmacovigilance. Council for International Organizations of Medical Sciences (CIOMS), Geneva, 2010.
4. CIOMS Working Group IV. Benefit-risk balance for marketed products: evaluating safety signals. Council for International Organizations of Medical Sciences (CIOMS), Geneva, 1999.